Parameters | |||||
---|---|---|---|---|---|
Groups | Haemorrhage and Congestion | Inflammatory Cell Infiltration | Necrosis | Degeneration | Edema |
Group 1 (PBS Control) | 0.0 ± 0.0a | 0.0 ± 0.0a | 0.0 ± 0.0a | 0.0 ± 0.0a | 0.0 ± 0.0a |
Group 2 (P.multocida B:2 Oral) | 0.42 ± 0.11b | 0.33 ± 0.10a | 0.81 ± 0.12b | 1.52 ± 0.10b | 0.17 ± 0.08a |
Group 3 (P.multocida B:2 Subcutaneous) | 2.50 ± 0.18c | 0.33 ± 0.10a | 1.64 ± 0.13c | 2.43 ± 0.15c | 0.42 ± 0.11b |
Group 4 (LPS Oral) | 0.58 ± 0.16b | 0.33 ± 0.16a | 0.75 ± 0.15b | 1.45 ± 0.12b | 0.25 ± 0.14a |
Group 5 (LPS Intravenous) | 0.67 ± 0.16b | 0.33 ± 0.16a | 0.80 ± 0.11b | 1.05 ± 0.15b | 0.17 ± 0.11a |
Group 6 (OMP Oral) | 2.58 ± 0.18b | 0.33 ± 0.14a | 1.35 ± 0.15c | 2.31 ± 0.15c | 0.50 ± 0.17b |
Group 7 (OMP Subcutaneous) | 2.75 ± 0.18c | 0.42 ± 0.14b | 1.55 ± 0.10c | 2.44 ± 0.12c | 0.42 ± 0.11b |